On Sunday, November 15th, and Monday, November 16th, Guidepoint Insights will be hosting a series of 45-minute virtual group meetings featuring KOLs who will dive deeper into the American Association for the Study of Liver Diseases (AASLD) data updates.

Topics of discussion will include:

  • Review of incremental data for NAFLD/NASH studies including REGENERATE(obeticholic acid), FLIGHT-FXR (tropifexor), MAESTRO-NAFLD-1 (resmetirom), FASCINATE-1 (TVB-2640), NATIVE (lanifibranor), BALANCED (efruxifermin), ATLAS (firsocostat/cilofexor), aldafermin, seladelpar, BIO89-100, AXA1125, AXA1957 among others
  • Thoughts on the long-term efficacy of obeticholic acid in PBC and potential opportunity for saroglitazar and linerixibat. Takeaways from INTREPID Study evaluating EDP-305 in PBC and potential read-through for ongoing ARGON-2 NASH trial
  • Discussion of therapeutic updates in hepatitis including vebicorvir, JNJ-0440, JNJ-3989, AB-729, RG6346, GSK3228836, ALG-000184, ISIS 505358, and others
  • Abstract review for rare cholestatic diseases: odevixibat and maralixibat


Complete the form below to request access:


    Sunday, November 15th

    10:00 AM ET - Brian Debosch

    • Assistant Professor, Pediatric Gastroenterology, Hepatology and Nutrition at Washington University, St. Louis

    11:00 AM ET - Joseph Lim

    • Professor of Medicine, Director of the Yale Viral Hepatitis Program, Co-Director Yale Liver Center at Yale University

    12:00 PM ET - Philip Rosenthal

    • Director of Pediatric Hepatology & Medical Director of the Pediatric Liver Transplant Program at The University of California, San Francisco

    1:00 PM ET - Robert Edward Schwartz

    • Gastroenterology and Hepatologist at New York Presbyterian Weill Cornell

    Monday, November 16th

    11:00 AM ET - Howard Worman

    • Physician at Icahn School of Medicine at Mount Sinai

    1:00 PM ET - Eric Lawitz

    • President and Medical Director at Texas Liver Institute

    2:00 PM ET - Raymond Chung

    • Associate Professor at Harvard Medical School

    3:00 PM ET - Stefan Zeuzem

    • Professor and Chief - Department of Medicine at Johann Wolfgang Goethe-Universität Frankfurt

    4:00 PM ET - Brett Fortune

    • Transplant Hepatologist at The New York and Presbyterian Hospital


    AASLD meetings will not be recorded and transcripts will not be available after the event. To recreate conditions similar to an in-person meeting, this event will be conducted as a Zoom meeting. As such, participants will be able to see/identify each other.